誉衡药业(002437.SZ)：目前佩玛贝特片尚未在国内销售

Core Viewpoint - Yuheng Pharmaceutical (002437.SZ) is collaborating with Japan's Kowa Company to promote Pemabate Tablets, aimed at adult patients with non-familial hypertriglyceridemia to lower triglyceride levels. The product is not yet available in the domestic market, but the company plans to initiate hospital entry and development work next year based on market conditions [1]. Group 1 - The product Pemabate Tablets is intended for adult patients with non-familial hypertriglyceridemia [1]. - The collaboration is between Yuheng Pharmaceutical and Kowa Company from Japan [1]. - The product is currently not available for sale in the domestic market [1]. Group 2 - The company anticipates starting hospital entry and related development work next year [1]. - The initiation of these activities will depend on market conditions [1].